title: Using Surveillance Data to Assess the HIV Tipping Point in the United States.
authors: *Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA †ICF International, Atlanta, GA ‡National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta Georgia.
authors: H Irene
authors: HI
authors: Hall
authors: Lorena
authors: L
authors: Espinoza
authors: Shericka
authors: S
authors: Harris
authors: Tian
authors: T
authors: Tang
authors: Jonathan
authors: J
authors: Mermin
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D062665:Epidemiological Monitoring; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D014481:United States / Q000453:epidemiology
chemical_list: D044966:Anti-Retroviral Agents
references: PLoS One. 2010 Jun 10;5(6):e11068
references: 20548786
references: Lancet. 2010 Aug 14;376(9740):532-9
references: 20638713
references: AIDS. 2014 Jan 2;28(1):105-14
references: 23942058
references: JAMA Intern Med. 2013 Jul 22;173(14):1337-44
references: 23780395
references: Lancet. 2009 Jan 3;373(9657):48-57
references: 19038438
references: N Engl J Med. 2011 Aug 11;365(6):493-505
references: 21767103
references: Science. 2013 Feb 22;339(6122):966-71
references: 23430656
references: JAMA. 2014 Jul 23-30;312(4):432-4
references: 25038362
references: AIDS. 2014 Jun 19;28(10):1509-19
references: 24809629